<A> comparison of pioglitazone with metformin in management of type 2 diabetes mellitus

Kashif, Razzaq; Waqar, Ahmed; Rabiah, Anwar; Ahmed Mushtaq, Khan; Muhammad Ali, Taj; Muhammad, Iqbal; Muhammad Ali, Yousaf.
PAFMJ-Pakistan Armed Forces Medical Journal. 2011; 61 (1): 25-31
en Inglés | IMEMR | ID: emr-110087

Documentos relacionados

  1. Meta-analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus.
  2. Genomic editing of metformin efficacy-associated genetic variants in SLC47A1 does not alter SLC47A1 expression.
  3. Anti-hyperglycemic effects of propolis or metformin in type 2 diabetes mellitus.
  4. <i>Nigella sativa</i> L. and Its Active Compound Thymoquinone in the Clinical Management of Diabetes: A Systematic Review.
  5. Randomized, Double-blind, Phase III Trial of Lobeglitazone Add-on to Metformin in Type 2 Diabetes (SENSITIZE INDIA).
  6. Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects.
  7. FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes.
  8. Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications.
  9. Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.
  10. Effect of Dietary Fiber on the Level of Free Hypoglycemic Agents in Vitro.